Genetics of amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Revue neurologique (Paris)

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurol.2017.03.030PMID 28449881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders

  2017cited by this paper
• Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.

  2016cited by this paper
• NEK1 mutations in familial amyotrophic lateral sclerosis.

  2016cited by this paper
• Distinct neurological disorders with C9orf72 mutations: genetics, pathogenesis, and therapy.

  2016cited by this paper
• Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

  2016cited by this paper
• NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

  2016cited by this paper
• Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes

  2016cited by this paper
• Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

  2016cited by this paper
• CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

  2016cited by this paper
• Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis

  2015cited by this paper
• Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

  2015cited by this paper
• Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology

  2015cited by this paper
• The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis

  2015cited by this paper
• De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients.

  2015cited by this paper
• Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

  2015cited by this paper
• Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

  2015cited by this paper
• TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.

  2015cited by this paper
• The cognitive profile of ALS: a systematic review and meta-analysis update

  2015cited by this paper
• Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD).

  2015cited by this paper
• Neurodegenerative disease: C9orf72 repeats compromise nucleocytoplasmic transport

  2015cited by this paper
• Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes

  2015cited by this paper
• C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome‐wide meta‐analysis

  2014cited by this paper
• Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

  2014cited by this paper
• Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis

  2014cited by this paper
• Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders

  2014cited by this paper
• Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study.

  2014cited by this paper
• Mechanisms of toxicity in C9FTLD/ALS

  2014cited by this paper
• A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.

  2014cited by this paper
• Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.

  2014cited by this paper
• Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.

  2014cited by this paper
• State of play in amyotrophic lateral sclerosis genetics

  2013cited by this paper
• Genetics of amyotrophic lateral sclerosis: an update

  2013cited by this paper
• Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.

  2013cited by this paper
• TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update

  2013cited by this paper
• Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology

  2013cited by this paper
• UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study.

  2013cited by this paper
• P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis.

  2012cited by this paper
• Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations

  2012cited by this paper
• Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients.

  2012cited by this paper
• Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

  2012cited by this paper
• Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics

  2012cited by this paper
• UNC13A is a modifier of survival in amyotrophic lateral sclerosis.

  2012cited by this paper
• Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.

  2012cited by this paper
• EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

  2012cited by this paper
• Molecular Mechanisms in Amyotrophic Lateral Sclerosis: The Role of Angiogenin, a Secreted RNase

  2012cited by this paper
• Direct Effects of Type I Interferons on Cells of the Immune System

  2011cited by this paper
• Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.

  2011cited by this paper
• Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.

  2011cited by this paper
• Ataxin-2 repeat-length variation and neurodegeneration.

  2011cited by this paper
• Proposed criteria for familial amyotrophic lateral sclerosis

  2011cited by this paper
• SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis.

  2011cited by this paper
• FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

  2011cited by this paper
• A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient.

  2011cited by this paper
• Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

  2011cited by this paper
• HFE polymorphisms affect cellular glutamate regulation.

  2011cited by this paper
• Senataxin modulates neurite growth through fibroblast growth factor 8 signalling.

  2011cited by this paper
• Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.

  2011cited by this paper
• Screening of OPTN in French familial amyotrophic lateral sclerosis.

  2011cited by this paper
• Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

  2011cited by this paper
• Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia

  2011cited by this paper
• No association of DPP6 with amyotrophic lateral sclerosis in an Italian population.

  2011cited by this paper
• Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population.

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort.

  2011cited by this paper
• Peripherin partially localizes in Bunina bodies in amyotrophic lateral sclerosis.

  2011cited by this paper
• Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis

  2011cited by this paper
• Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

  2011cited by this paper
• Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2

  2011cited by this paper
• Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.

  2011cited by this paper
• Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis.

  2011cited by this paper
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia

  2011cited by this paper
• Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression

  2011cited by this paper
• A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis

  2011cited by this paper
• Nuclear transport impairment of amyotrophic lateral sclerosis‐linked mutations in FUS/TLS

  2011cited by this paper
• HFE gene variants affect iron in the brain.

  2011cited by this paper
• Mutant HFE H63D Protein Is Associated with Prolonged Endoplasmic Reticulum Stress and Increased Neuronal Vulnerability*

  2011cited by this paper
• H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China

  2011cited by this paper
• Optineurin mutations in Japanese amyotrophic lateral sclerosis

  2011cited by this paper
• Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.

  2011cited by this paper
• Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.

  2011cited by this paper
• Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination

  2011cited by this paper
• Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis

  2011cited by this paper
• Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.

  2011cited by this paper
• Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

  2011cited by this paper
• Lack of association of PON polymorphisms with sporadic ALS in an Italian population.

  2011cited by this paper
• Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS

  2011cited by this paper
• MOB control: reviewing a conserved family of kinase regulators.

  2011cited by this paper
• A Yeast Model of FUS/TLS-Dependent Cytotoxicity

  2011cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis

  2010cited by this paper
• Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations

  2010cited by this paper
• Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis.

  2010cited by this paper
• FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis

  2010cited by this paper
• Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.

  2010cited by this paper
• ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import

  2010cited by this paper
• Exome sequencing reveals VCP mutations as a cause of familial ALS.

  2010cited by this paper
• Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?

  2010cited by this paper
• An estimate of amyotrophic lateral sclerosis heritability using twin data

  2010cited by this paper
• CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines

  2010cited by this paper

• Granules Gone Rogue: Nuclear and Cytoplasmic Ribonucleoprotein Structures in Amyotrophic Lateral Sclerosis-Fused in Sarcoma (ALS-FUS) Pathology

  2026cites this paper
• Clinical trajectories and genetic profiles of SOD1-related amyotrophic lateral sclerosis: insights from a single-center cohort in India

  2026cites this paper
• A Qualitive Investigation of Geographic Disparities in Genetic Testing and Care Access for Amyotrophic Lateral Sclerosis: Insights From Patient Journey Mapping

  2026influential citation
• TAX1BP1 recruitment reactivates autophagy of Tau aggregates through ULK1 and TBK1

  2026cites this paper
• Neurofilament light chain dynamics in the pre-symptomatic phase of amyotrophic lateral sclerosis: a case report

  2025cites this paper
• An unrecognized mechanism of self-protection in degenerating neurons mediated by astrocytic YAP through Wnts/β-catenin/EAAT2 signaling in C9orf72-poly-GA mice

  2025cites this paper
• Glycerophospholipids in ALS: insights into disease mechanisms and clinical implication

  2025cites this paper
• A Blood Transcriptomic Resource for ALS Highlights Disease-Associated Signatures and Alternative Splicing Events

  2025cites this paper
• Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis

  2025cites this paper
• ALS global day 2025: research and clinical advances

  2025cites this paper
• RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights

  2025cites this paper
• Oral Inhaled Cromolyn for Mild-to-Moderate Amyotrophic Lateral Sclerosis: A Randomized, Open Label Phase 2a Study.

  2025cites this paper
• Evaluation of Inspiratory Muscle Training Effect Compared With Diaphragmatic Breathing in Respiratory Parameters in Amyotrophic Lateral Sclerosis Patients: A Randomized Controlled Trial

  2025cites this paper
• Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View

  2025cites this paper
• Clinical Features, Diagnostic Implications, and Outcomes of Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Systematic Review

  2025cites this paper
• Positive modulation of sigma-1 receptor: a new weapon to mitigate disease progression in amyotrophic lateral sclerosis

  2025cites this paper
• Inhibition of Salt‐Inducible Kinase 2 Protects Motor Neurons From Degeneration in ALS by Activating Autophagic Flux and Enhancing mTORC1 Activity

  2025cites this paper
• Astrocytic activation of EMMPRIN contributes to their pathological phenotype in ALS

  2025cites this paper
• Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72-ALS/FTD Microglia

  2025cites this paper
• Integrative analysis of transcriptomics and drug-target networks identifies SMN1 as a novel biomarker and therapeutic target for amyotrophic lateral sclerosis

  2025cites this paper
• Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics

  2025cites this paper
• Targeting mitophagy in neurodegenerative diseases

  2025influential citation
• NERP-1 modifications in amyotrophic lateral sclerosis.

  2025cites this paper
• Superoxide dismutase impacts extracellular vesicle biogenesis and uptake

  2025cites this paper
• TDP-43 pathology triggers SRRM4-dependent cryptic splicing of G3BP1 in ALS/FTD

  2025cites this paper
• Brain metabolic imaging with 18 F-PET-CT and machine-learning clustering analysis reveal divergent metabolic phenotypes in patients with amyotrophic lateral sclerosis

  2025cites this paper
• In-cell processing enables rapid and in-depth proteome analysis of low-input Caenorhabditis elegans

  2024cites this paper
• SOD1 controls neutrophil oxidative burst and microbial killing

  2024cites this paper
• Exome-wide analysis of congenital kidney anomalies reveals new genes and shared architecture with developmental disorders

  2024cites this paper
• Learning good therapeutic targets in ALS, neurodegeneration, using observational studies

  2024cites this paper
• N-Terminal Fragments of TDP-43—In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

  2024cites this paper
• Neurodegenerative diseases - Characteristics and The role of physical activity

  2024cites this paper
• Aberrant protein aggregation in amyotrophic lateral sclerosis

  2024cites this paper
• The role of statins in amyotrophic lateral sclerosis: protective or not?

  2024cites this paper
• Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications

  2024cites this paper
• A mutation in the PRKAR1B gene drives pathological mechanisms of neurodegeneration across species

  2024cites this paper
• A stress-dependent TDP-43 SUMOylation program preserves neuronal function

  2024cites this paper
• The Role of Cardiolipin in Mitochondrial Function and Neurodegenerative Diseases

  2024cites this paper
• Mitochondrial and Nuclear DNA Variants in Amyotrophic Lateral Sclerosis: Enrichment in the Mitochondrial Control Region and Sirtuin Pathway Genes in Spinal Cord Tissue

  2024cites this paper
• Nicotinamide Adenine Dinucleotide Precursor Supplementation Modulates Neurite Complexity and Survival in Motor Neurons from Amyotrophic Lateral Sclerosis Models

  2024cites this paper
• Altered nuclear envelope homeostasis is a key pathogenic event in C9ORF72-linked ALS/FTD

  2024cites this paper
• New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Establishment of a novel amyotrophic lateral sclerosis patient-derived blood-brain barrier model: Investigating barrier dysfunction and immune cell interaction

  2024cites this paper
• Combinatorial network of transcriptional and post-transcriptional regulation in amyotrophic lateral sclerosis

  2024cites this paper
• Genetic analysis of Indian sporadic young onset patient with Amyotrophic Lateral Sclerosis

  2023cites this paper
• Nuclear pore complex and nucleocytoplasmic transport disruption in neurodegeneration

  2023cites this paper
• Identifying dysregulated regions in amyotrophic lateral sclerosis through chromatin accessibility outliers

  2023cites this paper
• Protein Assembly Modulation: A New Approach to ALS Therapeutics

  2023cites this paper
• Mitochondria as intracellular signalling organelles. An update.

  2023cites this paper
• Guideline “Motor neuron diseases” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie)

  2023cites this paper
• Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis

  2023cites this paper
• Genetic Interaction of tRNA-Dependent Mistranslation with Fused in Sarcoma Protein Aggregates

  2023cites this paper
• Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis

  2023cites this paper
• Presence of Rare Variants is Associated with Poorer Survival in Chinese Patients with Amyotrophic Lateral Sclerosis

  2023cites this paper
• Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series.

  2023cites this paper
• In Vitro 3D Modeling of Neurodegenerative Diseases

  2023cites this paper
• Divergent Molecular Pathways for Toxicity of Selected Mutant C9ORF72-derived Dipeptide Repeats

  2023cites this paper
• Uncovering mirror neurons’ molecular identity by single cell transcriptomics and microarray analysis

  2023cites this paper
• RNA-Binding Proteins: A Role in Neurotoxicity?

  2023influential citation
• ALS and the Gut-Brain Axis: A protocol for a systematic review and meta-analysis assessing the relationship between amyotrophic lateral sclerosis, the gut and its microbiome.

  2023cites this paper
• Multiple roles for the cytoskeleton in ALS

  2022cites this paper
• Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study

  2022cites this paper
• RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia

  2022cites this paper
• The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals

  2022cites this paper
• A Cellular Taxonomy of the Adult Human Spinal Cord

  2022cites this paper
• The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  2022cites this paper
• Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4

  2022cites this paper
• Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis

  2022cites this paper
• The Human Motoneuron Expression Signature is Defined by ALS-Related Genes

  2022cites this paper
• Role of Inspiratory Muscle Training on Pulmonary Rehabilitation in Patients with COVID-19: A Pilot Study

  2022cites this paper
• Reduced-penetrance Huntington’s disease-causing alleles with 39 CAG trinucleotide repeats could be a genetic factor of amyotrophic lateral sclerosis

  2022cites this paper
• Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival

  2022cites this paper
• Modeling neuromuscular diseases in zebrafish

  2022cites this paper
• The Role of Epigenetics in Neuroinflammatory-Driven Diseases

  2022cites this paper
• Tissue‐engineered in vitro modeling of the impact of Schwann cells in amyotrophic lateral sclerosis

  2022cites this paper
• Recent insights into the roles of circular RNAs in human brain development and neurologic diseases.

  2022cites this paper
• Clinical and epidemiological characteristics of patients with Amyotrophic Lateral Sclerosis (ALS) in central Brazil

  2022cites this paper
• Lack of an association between SCFD1 rs10139154 polymorphism and amyotrophic lateral sclerosis

  2022cites this paper
• Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia

  2022cites this paper
• Blood biomarkers in ALS: challenges, applications and novel frontiers

  2022cites this paper
• Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases.

  2022cites this paper
• Update on genetics of amyotrophic lateral sclerosis

  2022cites this paper
• FUS as a cause of familial Amyotrophic lateral sclerosis, a case report in a pregnant patient

  2022cites this paper
• Potential Common Genetic Risks of Sporadic Parkinson’s Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China

  2021cites this paper
• Mitophagy Modulation, a New Player in the Race against ALS

  2021influential citation
• Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2021influential citation
• Crucial roles of different RNA-binding hnRNP proteins in Stem Cells

  2021cites this paper
• Overview of stem cells therapy in amyotrophic lateral sclerosis

  2021influential citation
• BMP/TGF‐β signaling as a modulator of neurodegeneration in ALS

  2021cites this paper
• Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum

  2021cites this paper
• Neurological Diseases and Mitochondrial Genes

  2021cites this paper
• Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases

  2021influential citation
• Autophagy and ALS: mechanistic insights and therapeutic implications

  2021cites this paper
• DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity

  2021cites this paper
• Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases

  2021cites this paper
• Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons

  2021cites this paper
• The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei

  2021cites this paper
• Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular degeneration in ALS.

  2021cites this paper
• The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Genetic Basis of ALS

  2021cites this paper